This news or article is intended for readers with certain scientific or professional knowledge in the field. Enzalutamide is one of the main treatments for patients with metastatic, castration-resistant prostate cancer — the lethal form of the disease. However, treatment options are limited for those who develop resistance to enzalutamide. Now, a multi-institution team has...
Dual inhibition of Aurora kinase A and JAK2 reduces graft-versus-host-disease, preserves the ability of the immune system to fight infections and tumor cells. Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer...
